c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

This publication has 36 references indexed in Scilit:

• Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients
  International Journal of Cancer, 2005
• Prognostic Significance of Co-expression of RON and MET Receptors in Node-Negative Breast Cancer Patients
  Clinical Cancer Research, 2005
• Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
  Journal of Clinical Oncology, 2005
• Tumor Neoangiogenesis by CD31 and CD105 Expression Evaluation in Breast Carcinoma Tissue Microarrays
  Clinical Cancer Research, 2004
• Met, metastasis, motility and more
  Nature Reviews Molecular Cell Biology, 2003
• Tissue microarray‐based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors
  Cancer, 2003
• Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
  Cancer Cell, 2003
• Scatter-factor and semaphorin receptors: cell signalling for invasive growth
  Nature Reviews Cancer, 2002
• c‐met tyrosine kinase receptor expression is associated with abnormal β‐catenin expression and favourable prognostic factors in invasive breast carcinoma
  Histopathology, 2000
• Quantitative Immuno cytochemical Assays of P-glycoprotein in Breast Carcinomas: Correlation to Messenger RNA Expression and to Immunohistochemical Prognostic Indicators
  JNCI Journal of the National Cancer Institute, 1994